Each discovery project has its specific requirements regarding assays, animal models, synthesis capacities, etc. Over the past decade, our team has developed a reliable preclinical research network of service partners. These have been carefully chosen and validated in previous projects.
During the design phase of new projects, 3BP and its pharmaceutical partner decide which tasks to best perform at 3BP, which activities should be conducted at their own R&D facilities, and which can be outsourced to service partners in the network. Customers typically appreciate the flexibility of this approach.